Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 20, 2018
The use of immunotherapy in the treatment of melanoma.
Journal: Journal of hematology & oncology
Published: January 10, 2017
Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab.
Journal: Journal of translational medicine
Published: November 23, 2016
Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma.
Journal: Journal of translational medicine
Published: April 10, 2015
Melanoma adjuvant therapy.
Journal: Hematology/oncology clinics of North America
Published: June 02, 2014
A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma.
Journal: Journal of translational medicine
Published: December 05, 2013
Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung cancer.
Journal: Anticancer research
Published: October 15, 2013
Tremelimumab: a review of development to date in solid tumors.
Journal: Immunotherapy
Published: March 01, 2013
Differing patterns of circulating regulatory T cells and myeloid-derived suppressor cells in metastatic melanoma patients receiving anti-CTLA4 antibody and interferon-α or TLR-9 agonist and GM-CSF with peptide vaccination.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: October 24, 2012
Last Updated: 09/26/2026